3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Suspended
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Pain
1
Interventions
Paclitaxel
5
Gemcitabine
3
Nivolumab
2
Injections
2
E 7107
2
Docetaxel
2
Carboplatin
2
Antibodies, Monoclonal
2
130-nm albumin-bound paclitaxel
2
venetoclax
1
trastuzumab biosimilar HLX02
1
taxane
1
spartalizumab
1
resiniferatoxin
1
poly(I).poly(c12,U)
1
pegamotecan
1
palbociclib
1
lenvatinib
1
imisopasem manganese
1
icotinib
1
gusacitinib
1
famitinib
1
eniluracil
1
dabrafenib
1
cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV))
1
cobimetinib
1
brincidofovir
1
ammonium trichloro(dioxoethylene-O,O'-)tellurate
1
aldesleukin
1
abivertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
INDUSTRY
×
Extracorporeal Shockwave Therapy
×
Clear all
NCT00637364
2009-01-13
HIFU Pancreas
CMED HIFU Development Corporation
Phase 1/2
Suspended
5 enrolled